EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving the clinical recognition, prognosis, and treatment of melioidosis through epidemiology and clinical findings: The Sabah perspective

Ainulkhir Hussin iD, Mohd Yusof Nor Rahim, Frederick Dalusim, Muhammad Ashraf Shahidan, Sheila Nathan, Nazlina Ibrahim iD

PLOS Neglected Tropical Diseases · 2023

DOI: 10.1371/journal.pntd.0011696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Ainulkhir Hussin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia. Hauptthemen laut MEDLINE: Melioidosis, Burkholderia pseudomallei, Diabetes Mellitus, Bacteremia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Melioidosis is a deadly endemic disease in northern Australia and Southeast Asia, including Sabah, Malaysia, which is caused by the bacterium Burkholderia pseudomallei . It contributes to high fatality rates, mainly due to misdiagnosis leading to the wrong treatment being administered to the patients. Local epidemiology and data on clinical features could assist clinicians during diagnosis and treatment. However, these details are still scarce, particularly in Sabah.

Methods

A retrospective study of 246 culture-confirmed melioidosis cases in Queen Elizabeth Hospital, Sabah, Malaysia was performed between 2016 and 2018. The epidemiological data and clinical and laboratory findings were extracted and analysed.

Results

The annual incidence of culture-confirmed melioidosis cases was estimated to be 4.97 per 100,000 people. The mean age of the patients was 50±15 years. Males and members of the Kadazan-Dusun ethnic group accounted for the majority of the melioidosis cases. The odds ratio analysis indicated that bacteraemic melioidosis in this region was significantly associated with fever (76%), and patients having at least one underlying illness (43%), including diabetes mellitus (32%). Sixty-eight patients (28%) succumbed to melioidosis. Contrary to what is known regarding factors that promote bacteraemic melioidosis, neither patients with fever nor patients with at least one comorbid disease, including diabetes mellitus, were significantly associated with death from melioidosis. There was no statistically significant difference between patients without comorbidities (24, 27%) and those with at least one comorbid disease (26, 25%), including diabetes mellitus (18, 23%). The odds ratios indicate that melioidosis mortality in this region is related to patients showing respiratory organ-associated symptoms (29%), bacteraemia (30%), and septic shock (47%). Burkholderia pseudomallei isolates in this study were highly susceptible to ceftazidime (100%), imipenem (100%), and trimethoprim-sulfamethoxazole (98%).

Conclusions

Information obtained from this study can be used by clinicians to recognise individuals with the highest risk of acquiring melioidosis, estimate an accurate prognosis, and provide effective treatment for melioidosis patients to reduce death from melioidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelioidosisBurkholderia pseudomalleiDiabetes MellitusBacteremiaMaleHumansAdultMiddle AgedAgedMalaysiaAnti-Bacterial AgentsRetrospective StudiesTreatment Outcome

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia.
  • Department of Pathology, Queen Elizabeth Hospital, Ministry of Health Malaysia, Kota Kinabalu, Sabah, Malaysia.

ORCID-Profile: Ainulkhir Hussin, Nazlina Ibrahim

Zitieren

APA

Hussin, A., Nor Rahim, M. Y., Dalusim, F., Shahidan, M. A., Nathan, S., & Ibrahim, N. (2023). Improving the clinical recognition, prognosis, and treatment of melioidosis through epidemiology and clinical findings: The Sabah perspective. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011696

Vancouver

Hussin A, Nor Rahim MY, Dalusim F, Shahidan MA, Nathan S, Ibrahim N. Improving the clinical recognition, prognosis, and treatment of melioidosis through epidemiology and clinical findings: The Sabah perspective. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011696

BibTeX
@article{Hussin2023,
  author = {Hussin, Ainulkhir and Nor Rahim, Mohd Yusof and Dalusim, Frederick and Shahidan, Muhammad Ashraf and Nathan, Sheila and Ibrahim, Nazlina},
  title = {Improving the clinical recognition, prognosis, and treatment of melioidosis through epidemiology and clinical findings: The Sabah perspective},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  doi = {10.1371/journal.pntd.0011696}
}
Kostenlos starten →